PTGX · Protagonist Therapeutics Inc
United States · RS rating 86 · As of 2026-11-03
| Price | 140.24 USD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 86 / 55 / 71 / 91 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 46 / 23 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -11.3% |
| Sales growth Q/Q | +57.8% |
| Distance from 52-week high | +11.6% |
| Market cap (USD) | $6.5B |